These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24533130)

  • 21. Clinical and magnetic resonance imaging predictors of very early neurological response to intravenous thrombolysis in patients with middle cerebral artery occlusion.
    Apoil M; Turc G; Tisserand M; Calvet D; Naggara O; Domigo V; Baron JC; Oppenheim C; Touzé E
    J Am Heart Assoc; 2013 Dec; 2(6):e000511. PubMed ID: 24308937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator.
    Linfante I; Llinas RH; Selim M; Chaves C; Kumar S; Parker RA; Caplan LR; Schlaug G
    Stroke; 2002 Aug; 33(8):2066-71. PubMed ID: 12154264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between different acute stroke therapies and development of post stroke seizures.
    Naylor J; Thevathasan A; Churilov L; Guo R; Xiong Y; Koome M; Chen Z; Chen Z; Liu X; Kwan P; Campbell BCV
    BMC Neurol; 2018 May; 18(1):61. PubMed ID: 29724190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of deep white matter lesions on diffusion-weighted imaging is a negative predictor of early dramatic improvement after intravenous tissue plasminogen activator thrombolysis.
    Kawano H; Hirano T; Inatomi Y; Terasaki T; Yonehara T; Uchino M
    Cerebrovasc Dis; 2010 Aug; 30(3):230-6. PubMed ID: 20606424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IV vs. IA TPA in acute ischemic stroke with CT angiographic evidence of major vessel occlusion: a feasibility study.
    Sen S; Huang DY; Akhavan O; Wilson S; Verro P; Solander S
    Neurocrit Care; 2009; 11(1):76-81. PubMed ID: 19277904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of Computed Tomographic Perfusion in Thrombolysis for Minor Stroke.
    Ng FC; Coote S; Frost T; Bladin C; Choi PM
    Stroke; 2016 Jul; 47(7):1914-6. PubMed ID: 27197850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Good outcome rate of 35% in IV-tPA-treated patients with computed tomography angiography confirmed severe anterior circulation occlusive stroke.
    González RG; Furie KL; Goldmacher GV; Smith WS; Kamalian S; Payabvash S; Harris GJ; Halpern EF; Koroshetz WJ; Camargo EC; Dillon WP; Lev MH
    Stroke; 2013 Nov; 44(11):3109-13. PubMed ID: 24003051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care.
    Paul CL; Ryan A; Rose S; Attia JR; Kerr E; Koller C; Levi CR
    Implement Sci; 2016 Apr; 11():51. PubMed ID: 27059183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of systemic inflammatory response syndrome in ischemic stroke undergoing systemic thrombolysis with intravenous tissue plasminogen activator.
    Boehme AK; Kapoor N; Albright KC; Lyerly MJ; Rawal PV; Bavarsad Shahripour R; Alvi M; Houston JT; Sisson A; Beasley TM; Alexandrov AW; Alexandrov AV; Miller DW
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e271-6. PubMed ID: 24424334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
    Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility and safety of intravenous thrombolysis in multiethnic Asian stroke patients in Singapore.
    Sharma VK; Tsivgoulis G; Tan JH; Wong LY; Ong BK; Chan BP; Teoh HL
    J Stroke Cerebrovasc Dis; 2010; 19(6):424-30. PubMed ID: 20554224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral Microbleeds are an Independent Predictor of Hemorrhagic Transformation Following Intravenous Alteplase Administration in Acute Ischemic Stroke.
    Nagaraja N; Tasneem N; Shaban A; Dandapat S; Ahmed U; Policeni B; Olalde H; Shim H; Samaniego EA; Pieper C; Ortega-Gutierrez S; Leira EC; Adams HP
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1403-1411. PubMed ID: 29398533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why are acute ischemic stroke patients not receiving IV tPA? Results from a national registry.
    Messé SR; Khatri P; Reeves MJ; Smith EE; Saver JL; Bhatt DL; Grau-Sepulveda MV; Cox M; Peterson ED; Fonarow GC; Schwamm LH
    Neurology; 2016 Oct; 87(15):1565-1574. PubMed ID: 27629092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients.
    Berrouschot J; Röther J; Glahn J; Kucinski T; Fiehler J; Thomalla G
    Stroke; 2005 Nov; 36(11):2421-5. PubMed ID: 16210554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
    Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors for Distal Clot Migration during Mechanical Thrombectomy of Anterior Circulation Large Vessel Occlusion.
    Mohammaden MH; Stapleton CJ; Brunozzi D; Khedr EM; Theiss P; Atwal G; Alaraj A
    Cerebrovasc Dis; 2020; 49(2):185-191. PubMed ID: 32224607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
    Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
    Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.